Sophia Bou-Ghannam
Senior Medical Science Liaison @Humacyte
Signup · Get unlimited contacts
WORK HISTORY
Senior Medical Science Liaison @Humacyte
EDUCATION
University of Florida
Bachelor of Science (B.S.), Biomedical Engineering
University of Utah
Doctor of Philosophy - PhD, Biomedical Engineering
SKILLS
ABOUT SOPHIA BOU-GHANNAM
Dr. Sophia Bou-Ghannam serves as Sr. Medical Publications & Medical Science Liaison at Humacyte, bringing a decade of clinical research experience in tissue engineering and regenerative medicine products. Dr. Bou-Ghannam holds a PhD in Biomedical Engineering from the University of Utah. She completed her doctoral training under Professors David W. Grainger and Teruo Okano, contributing significant advancements in allogeneic stem cell therapies. Throughout her career, Dr. Bou-Ghannam has authored more than 10 peer-reviewed publications demonstrating the clinical utility of Mesenchymal Stem Cells (MSCs) for treating a variety of complex fibrotic and degenerative diseases, including cardiomyopathy, liver fibrosis, and orthopedic defects. Her original research focused on engineering MSCs in such a way as to augment their intrinsic pro-regenerative and anti-inflammatory capacity and maximize their ability to act as bioactive factor delivery depots upon transplantation. Dr. Bou-Ghannam was awarded a Whitaker International Fellowship to conduct translational stem cell research at Tokyo Women’s Medical University in Tokyo, Japan. This tenure produced extensive, original research on engineered MSC sheets in fibrotic mitigation and repair post-myocardial infarction in pre-clinical models. Dr. Bou-Ghannam previously held the role of Cell Line Development Lead at a prominent company specializing in the large-scale production of stem cells for commercial applications. In this role, she led a team of scientists in designing and optimizing experiments related to cell line performance. Dr. Bou-Ghannam leveraged skills in regulatory strategy and writing, presenting to regulatory agencies, and responding to their inquiries, successfully navigating complex regulatory pathways to support biologic product approvals by the US FDA.Dr. Bou-Ghannam joined Humacyte to leverage her extensive experience in advanced biologics, their manufacturing, and their regulatory pathways to support the clinical implementation of regenerative medicine technologies at all stages of clinical development and in post-market use.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.